Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 090363
Company: PIRAMAL CRITICAL
Company: PIRAMAL CRITICAL
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DESFLURANE | DESFLURANE | 100% | LIQUID;INHALATION | Prescription | AN | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 10/05/2026 | ORIG-1 | Approval |
Label is not available on this site. |
DESFLURANE
LIQUID;INHALATION; 100%
TE Code = AN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DESFLURANE | DESFLURANE | 100% | LIQUID;INHALATION | Prescription | No | AN | 090363 | PIRAMAL CRITICAL |
| SUPRANE | DESFLURANE | 100% | LIQUID;INHALATION | Prescription | Yes | AN | 020118 | BAXTER HLTHCARE |